# Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease

> **NCT03414788** · PHASE1 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Inflammatory Bowel Disease

## Interventions

- **BIOLOGICAL:** PF 06687234
- **BIOLOGICAL:** [124I]IB PF 06687234

## Key facts

- **NCT ID:** NCT03414788
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12-07
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn due to not being able to recruit subjects.
- **Last updated:** 2020-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03414788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03414788, "Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03414788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*